<p>(A) Inhibitory effects of NVP-BEZ235 on NPC cells and normal nasopharyngeal cells. Cells were cultured at 8,000∼10,000 cells/well in 96-well plates and cell growth was assessed by MTT methods after 3 days of treatment with NVP-BEZ235 (0–5000 nM).The results were expressed as inhibitory rates of cells. n = 3,<b>*</b><i>P</i><0.05, <b># </b><i>P</i><0.01, inhibitory rates of the corresponding concentration from NPC cells <i>vs.</i> NP69 cells. The inhibitory rate was calculated by following formula: A = (1-X/Y) ×100%. A, inhibitory rate; X, the average absorbance values of experimental groups; Y, the average absorbance values of control groups. (B) Inhibitory effects of NVP-BEZ235 on NPC cells with treatment for 7 days. Cells were culture...
<p>Cells were treated with NTP alone or in combination with gemcitabine. Cell viability was determin...
<p>(A–D) Cells (5×10<sup>5</sup>) were seeded in the presence of 10% serum and treated with NVP-BEZ2...
<p><b>Panel A</b>: HCC2935 and H2170 cells were treated with the indicated concentration of NVP-BKM1...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
<p>(A) (B) Combination of CDDP and NVP-BEZ235 synergistically inhibited cell proliferation. Cells we...
<p>(A) (B) NVP-BEZ235 blocked the phosphorylation of AKT, GSK3β, PRAS40, mTOR, S6K and 4E-BP1 in CNE...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
<p>Female NMRI-Foxn1<sup>nu</sup> mice were inoculated with HMC-1.2 cells and were randomized into a...
<p>A: HMC-1.1 cells (upper panel), HMC-1.2 cells (middle panel), and KU812 cells (lower panel) were ...
<p>(A) Cell viability of mutant and wild-type isogenic <i>PIK3CA</i> cells was assessed by MTS assay...
<p>(A) NVP-BEZ235 increased G1 phase cells population. Cells were cultured at the density of 0.5∼1×1...
<p>(A) (B) The antitumor efficacies of NVP-BEZ235, CDDP and combination of NVP-BEZ235and CDDP in CNE...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
<p><b>(A)</b> Inhibitory effect of NASTRp on cell proliferation in human lung cancer cell lines. A54...
<p>Caki cells were treated with the indicated concentrations of NVP-BEZ235 for 48 h. (A) Equal amoun...
<p>Cells were treated with NTP alone or in combination with gemcitabine. Cell viability was determin...
<p>(A–D) Cells (5×10<sup>5</sup>) were seeded in the presence of 10% serum and treated with NVP-BEZ2...
<p><b>Panel A</b>: HCC2935 and H2170 cells were treated with the indicated concentration of NVP-BKM1...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
<p>(A) (B) Combination of CDDP and NVP-BEZ235 synergistically inhibited cell proliferation. Cells we...
<p>(A) (B) NVP-BEZ235 blocked the phosphorylation of AKT, GSK3β, PRAS40, mTOR, S6K and 4E-BP1 in CNE...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
<p>Female NMRI-Foxn1<sup>nu</sup> mice were inoculated with HMC-1.2 cells and were randomized into a...
<p>A: HMC-1.1 cells (upper panel), HMC-1.2 cells (middle panel), and KU812 cells (lower panel) were ...
<p>(A) Cell viability of mutant and wild-type isogenic <i>PIK3CA</i> cells was assessed by MTS assay...
<p>(A) NVP-BEZ235 increased G1 phase cells population. Cells were cultured at the density of 0.5∼1×1...
<p>(A) (B) The antitumor efficacies of NVP-BEZ235, CDDP and combination of NVP-BEZ235and CDDP in CNE...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
<p><b>(A)</b> Inhibitory effect of NASTRp on cell proliferation in human lung cancer cell lines. A54...
<p>Caki cells were treated with the indicated concentrations of NVP-BEZ235 for 48 h. (A) Equal amoun...
<p>Cells were treated with NTP alone or in combination with gemcitabine. Cell viability was determin...
<p>(A–D) Cells (5×10<sup>5</sup>) were seeded in the presence of 10% serum and treated with NVP-BEZ2...
<p><b>Panel A</b>: HCC2935 and H2170 cells were treated with the indicated concentration of NVP-BKM1...